Astra To Continue Pulmicort Manufacturing Talks With FDA
Executive Summary
Astra is in discussions with FDA regarding "restrictive manufacturing specifications" applying to the firm's dry powder inhaled asthma therapy Pulmicort Turbuhaler, the company said.